Bristol-Myers Squibb
BMY
$48.99
Share price
-0.31%
Change (1 day)
-30.55%
Change (1 year)
Categories
Revenue for Bristol-Myers Squibb (BMY)
Revenue in 2023 (TTM): $45.00 B
According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM) is $45.00 B. In 2022 the company made a revenue of $46.15 B a decrease over the years 2021 revenue that were of $46.38 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bristol-Myers Squibb from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $45.00 B | -2.5% |
| 2022 | $46.15 B | -0.49% |
| 2021 | $46.38 B | 9.09% |
| 2020 | $42.51 B | 62.62% |
| 2019 | $26.14 B | 15.89% |
| 2018 | $22.56 B | 8.59% |
| 2017 | $20.77 B | 6.94% |
| 2016 | $19.42 B | 17.31% |
| 2015 | $16.56 B | 4.29% |
| 2014 | $15.87 B | -3.09% |
| 2013 | $16.38 B | -7.01% |
| 2012 | $17.62 B | -17.05% |
| 2011 | $21.24 B | 9.03% |
| 2010 | $19.48 B | 16.69% |
| 2009 | $16.69 B | -18.93% |
| 2008 | $20.59 B | 12.66% |
| 2007 | $18.28 B | 2.06% |
| 2006 | $17.91 B | -6.73% |
| 2005 | $19.20 B | 9.35% |
| 2004 | $17.56 B | -16.45% |
| 2003 | $21.02 B | 16.03% |
| 2002 | $18.11 B | -5.53% |
| 2001 | $19.18 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 106.69% | 🇺🇸 USA |
 Novartis NVS | $51.01 B | 13.34% | 🇨🇭 Switzerland |
 Pfizer PFE | $58.49 B | 29.98% | 🇺🇸 USA |
 AbbVie ABBV | $54.31 B | 20.69% | 🇺🇸 USA |
 Eli Lilly LLY | $34.12 B | -24.18% | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | -37.36% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 11.90% | 🇫🇷 France |
 Biogen BIIB | $9.83 B | -78.15% | 🇺🇸 USA |
 Merck MRK | $60.11 B | 33.57% | 🇺🇸 USA |
 AstraZeneca AZN | $45.81 B | 1.79% | 🇬🇧 UK |